D-0531-2020 Class II Terminated
FDA drug recall D-0531-2020 was initiated by Preferred Pharmaceuticals, Inc on November 21, 2019 and is designated Class II. Reason for recall: Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing. The recall status is terminated (terminated May 11, 2023).
Recall Details
- Product Type
- Drugs
- Report Date
- December 4, 2019
- Initiation Date
- November 21, 2019
- Termination Date
- May 11, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
Product Description
Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl.oz. 118 mL, Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA. Mfg: Taro Pharm.; Hawthorne, NY; NDC 68788-7268-01
Reason for Recall
Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Distribution Pattern
CA, FL, IL
Code Information
Lot #: I1718U, Exp. 3/2020; K0818L, Exp. 9/2020; L2718E, Exp. 9/2020; A2219E, Exp. 9/2020; C1519S, Exp. 12/2020; C2819Y, Exp. 12/2020; E2019V, Exp. 11/2020